Abstract No. 219: Correlation of survival and tumor response with WHO, RECIST, EASL and mRECIST criteria after doxorubicin drug eluting beads transarterial chemoembolization (DEB TACE) in unresectable hepatocellular carcinoma (HCC)

✍ Scribed by Prajapati, H.J.; Chen, Z.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; Kim, H.S.

• Book ID: 122611578
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 46 KB
• Volume: 23
• Category: Article
• ISSN: 1051-0443
• DOI: 10.1016/j.jvir.2011.12.268